scholarly article | Q13442814 |
P50 | author | Scott C. Weaver | Q22583669 |
Slobodan Paessler | Q28048960 | ||
Ilya Frolov | Q42428105 | ||
Gerald A. Campbell | Q49087537 | ||
Nadezhda Yun | Q117532844 | ||
P2093 | author name string | Barbara M Judy | |
D Mark Estes | |||
Natallia Dziuba | |||
Michele A Zacks | |||
Anna H Grund | |||
P2860 | cites work | Initial sequencing and comparative analysis of the mouse genome | Q22122521 |
Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation | Q27473190 | ||
Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs | Q27486072 | ||
The function of gammadelta T cells in innate immunity | Q28285687 | ||
Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro | Q33754953 | ||
Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus | Q33908923 | ||
Host range, amplification and arboviral disease emergence. | Q33992289 | ||
Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses | Q34434918 | ||
Immunoregulation in the tissues by gammadelta T cells | Q35092547 | ||
Immune-mediated clearance of virus from the central nervous system | Q35124033 | ||
Venezuelan equine encephalitis | Q35598701 | ||
Oligonucleotide mapping: evaluation of its sensitivity by computer-simulation | Q35680806 | ||
Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. | Q35797635 | ||
Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic | Q35802862 | ||
Histopathology and distribution of viral antigens in hamsters infected with virulent and benign Venezuelan encephalitis viruses | Q35864433 | ||
Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis | Q36685059 | ||
Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group | Q39582642 | ||
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles | Q39588679 | ||
Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis | Q40727814 | ||
Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate | Q41127255 | ||
The systemic pathology of Venezuelan equine encephalitis virus infection in humans | Q41488708 | ||
Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication | Q41658888 | ||
The role of antibody in recovery from alphavirus encephalitis | Q41672969 | ||
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages | Q44151375 | ||
Attenuated Mutants of Venezuelan Equine Encephalitis Virus Containing Lethal Mutations in the PE2 Cleavage Signal Combined with a Second-Site Suppressor Mutation in E1 | Q44169045 | ||
Spread of Venezuelan equine encephalitis virus in mice olfactory tract | Q44519610 | ||
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide | Q45246812 | ||
Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice | Q45729239 | ||
Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus | Q45751660 | ||
Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse | Q45785790 | ||
Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice | Q45856104 | ||
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene | Q46098688 | ||
Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation | Q46763975 | ||
Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells. | Q51983557 | ||
Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. | Q54231147 | ||
Interferon‐γ–Mediated Antiviral Immunity against Orthopoxvirus Infection Is Provided by γδ T Cells | Q56790347 | ||
Cytokine and chemokine inter-regulation in the inflamed or injured CNS | Q57042010 | ||
T cell receptor δ gene mutant mice: Independent generation of αβ T cells and programmed rearrangements of γδ TCR genes | Q57557410 | ||
Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis | Q59070308 | ||
The inter-relatedness and interdependence of mouse T cell receptor γδ+ and αβ+ cells | Q60241868 | ||
Immune response in mice that lack the interferon-gamma receptor | Q62022366 | ||
Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production | Q70338857 | ||
Bacterial infection of the testis leading to autoaggressive immunity triggers apparently opposed responses of alpha beta and gamma delta T cells | Q71961225 | ||
Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism | Q81621858 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | encephalitis | Q199615 |
murine model | Q122890741 | ||
P304 | page(s) | 307-23 | |
P577 | publication date | 2007-10-25 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection | |
P478 | volume | 367 |
Q39809317 | 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus |
Q35066196 | A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates |
Q55400521 | A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encepha |
Q36506753 | A chimeric vesiculo/alphavirus is an effective alphavirus vaccine |
Q33945612 | A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice |
Q41852978 | Adaptive immune response to viral infections in the central nervous system |
Q37341090 | CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus |
Q34810471 | CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice. |
Q23667364 | Characterization of a Novel Murine Model to Study Zika Virus |
Q39172123 | Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice |
Q64252263 | Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development |
Q36525351 | Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection |
Q24655184 | Encephalitic alphaviruses |
Q33803787 | Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus |
Q37156478 | IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice |
Q34723422 | IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety |
Q45372954 | Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates |
Q27489413 | Improved Efficacy of a Gene Optimised Adenovirus-based Vaccine for Venezuelan Equine Encephalitis Virus |
Q42428085 | Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein. |
Q27704471 | Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease |
Q37607095 | Live, Attenuated Venezuelan Equine Encephalitis Virus Vaccine (TC83) Causes Persistent Brain Infection in Mice with Non-functional αβ T-Cells |
Q35034663 | Mice deficient in interferon-gamma or interferon-gamma receptor 1 have distinct inflammatory responses to acute viral encephalomyelitis |
Q37993737 | Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology |
Q36638310 | Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan equine encephalitis virus in C3H/HeN mice |
Q26744571 | Neurological Sequelae Resulting from Encephalitic Alphavirus Infection |
Q38130786 | Pathogenesis of Venezuelan equine encephalitis |
Q28384852 | Principles of antidote pharmacology: an update on prophylaxis, post‐exposure treatment recommendations and research initiatives for biological agents |
Q24608725 | Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling |
Q39191007 | Production of IL-8, IL-17, IFN-gamma and IP-10 in human astrocytes correlates with alphavirus attenuation |
Q37955411 | Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe? |
Q91631072 | Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice |
Q64375183 | T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders |
Q39706214 | TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs |
Q27490196 | Vaccines for Venezuelan equine encephalitis |
Q26314703 | γδ T Cells Play a Protective Role in Chikungunya Virus-Induced Disease |